Antibody-Drug Conjugates: Supercharging the Blockbuster Antibody Class

Moderator:

  • Jeff Bockman, PhD, VP, Defined Health

Panelists:

  • Robert Cohen, MD, Calico Life Sciences
  • Jonathan Drachman, MD, SVP, Research and Translational Medicine, Seattle Genetics
  • Hans-Peter Gerber, PhD, VP, BioConjugate Discovery & Development, Oncology Research, Pfizer
  • John Lambert, PhD, EVP, Research & Development & Chief Scientific Officer, ImmunoGen, Inc.
  • Peter Kiener, Ph D, Chief Scientific Officer, Ambrx, Inc.